Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2011 Apr 13;2011(4):CD002041.
doi: 10.1002/14651858.CD002041.pub3.

Hyperbaric oxygen for carbon monoxide poisoning

Nick A Buckley  1 , David N Juurlink, Geoff Isbister, Michael H Bennett, Eric J Lavonas
Affiliations
Meta-Analysis

Hyperbaric oxygen for carbon monoxide poisoning

Nick A Buckley et al. Cochrane Database Syst Rev. .

Abstract

Background: Poisoning with carbon monoxide (CO) remains an important cause of accidental and intentional injury worldwide. Several unblinded non-randomized trials have suggested that the use of hyperbaric oxygen (HBO) prevents the development of neurological sequelae. This has led to the widespread use of HBO in the management of patients with carbon monoxide poisoning.

Objectives: To examine randomised trials of the efficacy of hyperbaric oxygen (HBO) compared to normobaric oxygen (NBO) for the prevention of neurologic sequelae in patients with acute carbon monoxide poisoning.

Search strategy: We searched the following electronic databases; Cochrane Injuries Group Specialised Register (searched June 2010), Cochrane Central Register of Controlled Trials (The Cochrane Library 2010, Issue 2), MEDLINE (Ovid SP) 1950 to June 2010, EMBASE (Ovid SP) 1980 to June 2010, ISI Web of Science: Science Citation Index Expanded (SCI-EXPANDED) 1970 to June 2010, ISI Web of Science: Conference Proceedings Citation Index-Science (CPCI-S) 1990 to June 2010.

Selection criteria: All randomised controlled trials of HBO compared to NBO, involving non-pregnant adults who are acutely poisoned with carbon monoxide (regardless of severity).

Data collection and analysis: Two authors independently extracted from each trial information on: the number of randomised patients, types of participants, the dose and duration of the intervention, and the prevalence of neurologic symptoms at follow-up.

Main results: Seven randomised controlled trials of varying quality were identified; one was excluded because it did not evaluate clinical outcomes. Of the six remaining trials involving 1361 participants, two found a beneficial effect of HBO for the reduction of neurologic sequelae at one month, while four others did not. One of these is an incomplete publication (an abstract of an interim analysis). Although pooled random effects meta-analysis does not suggest a significant benefit from HBOT (OR for neurological deficits 0.78, 95%CI 0.54 to 1.12), significant methodologic and statistical heterogeneity was apparent among the trials, and this result should be interpreted cautiously. Moreover, design or analysis flaws were evident in all trials. Importantly, the conclusions of one positive trial may have been influenced by failure to adjust for multiple hypothesis testing, while interpretation of the other positive trial is hampered by a high risk of bias introduced during the analysis including an apparent change in the primary outcome. Both were also stopped early 'for benefit', which is likely to have inflated the observed effect. In contrast three negative trials had low power to detect a benefit of HBO due to exclusion of severely poisoned patients in two and very poor follow-up in the other. One trial that was said to be finished around eight years ago has not reported the final analysis in any forum.

Authors' conclusions: Existing randomised trials do not establish whether the administration of HBO to patients with carbon monoxide poisoning reduces the incidence of adverse neurologic outcomes. Additional research is needed to better define the role, if any, of HBO in the treatment of patients with carbon monoxide poisoning. This research question is ideally suited to a multi-center randomised controlled trial.

PubMed Disclaimer

Conflict of interest statement

NB, DJ, GI, MB: None known. EL: From 2000 ‐ 2002 and 2006 ‐ 2008, Dr. Lavonas served as medical director of the hyperbaric medicine unit at Carolinas Medical Center, Charlotte, North Carolina, USA. Dr. Lavonas left that institution in 2008, and the emergency hyperbaric unit was closed in 2009. Dr. Lavonas reports no current competing interests involving the subject of this review.

Figures

1.1
1.1. Analysis
Comparison 1 Hyperbaric Oxygen (HBO) vs. Normobaric Oxygen (NBO), Outcome 1 Presence of symptoms or signs at time of primary analysis (4‐6 weeks).
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Annane 2010 {published and unpublished data}
    1. Annane D, Chadda K, Gajdos P, Jars‐Guincestre M‐C, Chevret S, Raphael J‐C. Hyperbaric oxygen therapy for acute domestic carbon monoxide poisoning: two randomized controlled trials. Intensive Care Medicine 2010;ePub (in press):DOI 10.1007/s00134‐010‐2093‐0. - PubMed
    1. Annane D, Raphael JC. Hyperbaric Oxygen Therapy for Comatose Patients With Acute Carbon Monoxide Poisoning. clinical trials.gov April 7 2010. [NCT01099995]
    1. Raphael JC, Chevret S, Driheme A, Annane D. Managing carbon monoxide poisoning with hyperbaric oxygen (Abstract). Journal of Toxicology ‐ Clinical Toxicology 2004;42:455‐6.
    1. University of Versaille. Hyperbaric Oxygen Therapy for Acute Domestic Carbon Monoxide (CO) Poisoning. clinicaltrials.gov April 8 2010. [NCT01100515]
Mathieu 1996 {published and unpublished data}
    1. Mathieu D, Wattel F, Mathieu‐Nolf M, Durak C, Tempe JP, Bouachour G, Sainty JM. Randomized prospective study comparing the effect of HBO vs. 12 hours NBO in non‐comatose CO‐poisoned patients: results of the preliminary analysis. Undersea & Hyperbaric Medicine 1996;23 Suppl:7 (abstract).
Raphael 1989 {published and unpublished data}
    1. Raphael JC, Elkharrat D, Jars‐Guincestre M‐C, Chastang C, Chasles V, Vercken J‐B, Gajdos P. Trial of normobaric and hyperbaric oxygen for acute carbon monoxide intoxication. Lancet 1989;2:414‐9. [MEDLINE: ] - PubMed
Scheinkestel 1999 {published and unpublished data}
    1. Scheinkestel CD, Bailey M, Myles PS, Jones K, Cooper JD, Millar IL, Tuxen DV. Hyperbaric or normobaric oxygen for acute carbon monoxide poisoning: a randomised controlled clinical trial. Medical Journal of Australia 1999;170:203‐10. [MEDLINE: ] - PubMed
    1. Scheinkestel CD, Jones K, Copper DJ, Millar I, Tuxen DV, Myles PS. Interim analysis ‐ controlled clinical trial of hyperbaric oxygen in acute carbon monoxide (CO) poisoning. Undersea & Hyperbaric Medicine 1996;23(suppl):7.
Thom 1995 {published and unpublished data}
    1. Thom SR, Taber RL, Mendiguren II, Clark JM, Hardy KR, Fisher AB. Delayed neurologic sequelae after carbon monoxide poisoning: prevention by treatment with hyperbaric oxygen. Annals of Emergency Medicine 1995;25:474‐80. [MEDLINE: ] - PubMed
    1. Thom SR, Taber RL, Mendiguren IL, Clark JM, Fisher AB. Delayed neurological sequelae following CO poisoning and the role of treatment with 100% O2 or hyperbaric oxygen ‐ A prospective randomized, clinical study. Undersea Biomedical Research 1992;19 (Suppl):47.
    1. Thoms SR. Hyperbaric oxygen therapy for carbon monoxide poisoning: is it time to end the debates?. Toxicological Reviews 2005;24(3):157‐8. - PubMed
Weaver 2002 {published data only}
    1. Weaver LK, Hopkins RO, Chan KJ, Churchill S, Elliott CG, Clemmer TP, Orme JF, Thomas FO, Morris AH. Hyperbaric oxygen for acute carbon monoxide poisoning. New England Journal of Medicine 2002;347(14):1057‐67. - PubMed
    1. Weaver LK, Hopkins RO, Larson Lohr V, Howe S, Haberstock D. Double blind, controlled, prospective, randomized clinical trial (RCT) in patients with acute carbon monoxide (CO) poisoning: outcome of patients treated with normobaric oxygen or hyperbaric oxygen (HBO) ‐ an interim report. Undersea and Hyperbaric Medicine 1995;22(suppl):14.
    1. Weaver LK, Hopkins RO, Valentine KJ, Churchill S. Persistent and delayed carbon monoxide cognitive sequelae. UHMS Meeting Abstracts 2005;http://archive.rubicon‐foundation.org/1788.
    1. Weaver LK, Valentine KJ, Hopkins RO. Carbon monoxide poisoning: risk factors for cognitive sequelae and the role of hyperbaric oxygen. American Journal of Respiratory and Critical Care Medicine 2007;176(5):491‐7. - PubMed

References to studies excluded from this review

Ducasse 1995 {published and unpublished data}
    1. Ducasse JL, Celsis P, Marc‐Vergnes JP. Non‐comatose patients with acute carbon monoxide poisoning: hyperbaric or normobaric oxygenation?. Undersea and Hyperbaric Medicine 1995;22:9‐15. [MEDLINE: ] - PubMed
Gao 2002 {published data only}
    1. Gao CJ, Ge H, Zhao LM, Wu LH, Xia CQ, Li Z, et al. Combined therapy with hyperbaric oxygen and anti‐platelet aggregation agent for the prevention of delayed encephalopathy after acute carbon monoxide poisoning. Chinese Journal of Nautical Medicine and hyperbaric medicine 2002;9(3):142‐4.
Hampson 2006 {published data only}
    1. Hampson NB, Dunford RG, Ross DE, Wreford‐Brown CE. A prospective, randomized clinical trial comparing two hyperbaric treatment protocols for carbon monoxide poisoning. Undersea & Hyperbaric Medicine: Journal of the Undersea and Hyperbaric Medical Society, Inc. 2006;33(1):27‐32. - PubMed
Hopkins 2007 {published data only}
    1. Hopkins RO, Weaver LK, Valentine KJ, Mower C, Churchill S, Carlquist J. Apolipoprotein E genotype and response of carbon monoxide poisoning to hyperbaric oxygen treatment. American journal of respiratory and critical care medicine 2007;176(10):1001‐6. - PubMed
Weaver 2007 {published data only}
    1. Weaver LK, Churchill S. One vs. Three Hyperbaric Oxygen Treatments for Acute Carbon Monoxide Poisoning. clinicaltrials.gov April 23, 2007.

Additional references

Bassler 2010
    1. Bassler D, Briel M, Montori VM, Lane M, Glasziou P, Zhou Q, et al. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta‐regression analysis. JAMA. 2010;303(12):1180‐7. - PubMed
Buckley 2005a
    1. Buckley NA, Isbister GK, Juurlink DN. Hyperbaric Oxygen for Carbon Monoxide Poisoning: Evidence versus Opinion. Toxicological Reviews 2005;24(3):159‐60. - PubMed
Bunc 2006
    1. Bunc M, Luzar B, Finderle Z, Suput D, Brvar M. Immediate oxygen therapy prevents brain cell injury in carbon monoxide poisoned rats without loss of consciousness. Toxicology 2006;225(2‐3):138‐41. [PUBMED: 16814444] - PubMed
Gilmer 2002
    1. Gilmer B, Kilkenny J, Tomaszewski C, Watts JA. Hyperbaric oxygen does not prevent neurologic sequelae after carbon monoxide poisoning. Academic emergency medicine: official journal of the Society for Academic Emergency Medicine 2002;9(1):1‐8. [PUBMED: 11772662] - PubMed
Hampson 2004
    1. Hampson NB, Mathieu D, Thom SR, Weaver LK. Carbon monoxide poisoning: interpretation of randomized clinical trials and unresolved treatment issues. Undersea & Hyperbaric Medicine 2001;28:157‐64. - PubMed
Hampson 2007
    1. Hampson NB, Weaver LK. Carbon monoxide poisoning: a new incidence for an old disease. Undersea & Hyperbaric Medicine: Journal of the Undersea and Hyperbaric Medical Society, Inc 2007;34(3):163‐8. - PubMed
Hampson 2008
    1. Hampson NB, Hauff NM. Carboxyhemoglobin levels in carbon monoxide poisoning: do they correlate with the clinical picture?. The American journal of emergency medicine 2008;26(6):665‐9. [PUBMED: 18606318] - PubMed
Higgins 2008
    1. Julian PT Higgins and Douglas G Altman on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, Available from www.cochrane‐handbook.org. The Cochrane Collaboration, 2008.
Jay 1997
    1. Jay GD, McKindley DS. Alterations in pharmacokinetics of carboxyhaemoglobin produced by oxygen under pressure. Undersea & Hyperbaric Medicine 1997;24:165‐74. - PubMed
Logue 2008
    1. Logue CJ. An inconvenient truth?. Annals of emergency medicine 2008; Vol. 51, issue 3:339‐40; author reply 340‐2. [PUBMED: 18282535] - PubMed
Morrison 2010
    1. Morrison LJ, Deakin CD, Morley PT, Callaway CW, Kerber RE, Kronick SL, et al. Part 8: advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation 2010;122(16 Suppl 2):S345‐421. [PUBMED: 20956256] - PubMed
Raphael 2004
    1. Raphael JC, Chevret S, Driheme A, Annane D. Managing carbon monoxide poisoning with hyperbaric oxygen (Abstract). Journal of Toxicology ‐ Clinical Toxicology 2004;42:455‐6.
Riley 2011
    1. Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects meta‐analyses. BMJ (Clinical research ed.) 2011;342:d549. [PUBMED: 21310794] - PubMed
Sackett 2001
    1. Sackett DL. Why randomized controlled trials fail but needn't: 2. Failure to employ physiological statistics, or the only formula a clinician‐trialist is ever likely to need (or understand!). CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2001;165(9):1226‐37. [PUBMED: 11706914] - PMC - PubMed
Sanders 2009
    1. Sanders RW, Katz KD, Suyama J, Akhtar J, O'Toole KS, Corll D, et al. Seizure during Hyperbaric Oxygen Therapy for Carbon Monoxide Toxicity: A Case Series and Five‐year Experience. Journal of Emergency Medicine 2009;ePub (in press):doi:10.1016/j.jemermed.2008.12.017. - PubMed
Stoller 2007
    1. Stoller KP. Hyperbaric oxygen and carbon monoxide poisoning: a critical review. Neurological Research 2007;29(2):146‐55. - PubMed
Thom 2002
    1. Thom SR. Carbon monoxide‐induced deficits in cognitive performance of mice and lack of effect of hyperbaric oxygen treatment. Academic Emergency Medicine 2002;9:75‐7. - PubMed
Thom 2006
    1. Thom SR, Bhopale VM, Fisher D. Hyperbaric oxygen reduces delayed immune‐mediated neuropathology in experimental carbon monoxide toxicity. Toxicology and applied pharmacology 2006;213(2):152‐9. [PUBMED: 16325878] - PubMed
Vanden Hoek 2010
    1. Vanden Hoek TL, Morrison LJ, Shuster M, Donnino M, Sinz E, Lavonas EJ, et al. Part 12: cardiac arrest in special situations: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010;122(18 Suppl 3):S829‐61. [PUBMED: 20956228] - PubMed
Weaver 1995
    1. Weaver LK, Hopkins RO, Larson‐Lohr A. Carbon monoxide poisoning: a review of human outcome studies comparing normobaric oxygen with hyperbaric oxygen. Annals of Emergency Medicine 1995;25(2):271‐2. - PubMed
Weaver 1995a
    1. Weaver LK, Hopkins RO, Larson‐Lohr V, Howe S, Haberstock D. Double blind, controlled, prospective, randomized clinical trial (RCT) in patients with acute carbon monoxide (CO) poisoning: Outcome of patients treated with normobaric oxygen or hyperbaric oxygen (HBO2) ‐ An interim report. Undersea & Hyperbaric Medicine. 1995; Vol. 22 (Suppl):14.
Weaver 1999
    1. Weaver LK. Carbon monoxide poisoning. Critical Care Clinics 1999;15:297‐317. - PubMed
Weaver 2001
    1. Weaver LK, Churchill S. Pulmonary edema associated with hyperbaric oxygen therapy. Chest. 2001;120(4):1407‐9. - PubMed
Weaver 2005
    1. Weaver LK, Hopkins RO, Valentine KJ, Churchill S. Persistent and delayed carbon monoxide cognitive sequelae. UHMS Meeting Abstracts. 2005; Vol. http://archive.rubicon‐foundation.org/1788.
Weaver 2007
    1. Weaver LK, Valentine KJ, Hopkins RO. Carbon monoxide poisoning: risk factors for cognitive sequelae and the role of hyperbaric oxygen. American journal of respiratory and critical care medicine 2007;176(5):491‐7. [PUBMED: 17496229] - PubMed
Weaver 2009
    1. Weaver LK. Clinical practice. Carbon monoxide poisoning. New England Journal of Medicine 2009;360(12):1217‐25. - PubMed
Wolf 2008
    1. Wolf SJ, Lavonas EJ, Sloan EP, Jagoda AS. Clinical policy: Critical issues in the management of adult patients presenting to the emergency department with acute carbon monoxide poisoning. Annals of Emergency Medicine 2008;51(2):138‐52. - PubMed

References to other published versions of this review

Buckley 2005
    1. Buckley NA, Isbister GK, Stokes B, Juurlink DN. Hyperbaric oxygen for carbon monoxide poisoning: a systematic review and critical analysis of the evidence. Toxicological Reviews 2005;24(2):75‐92. - PubMed
Juurlink 2005
    1. Juurlink D, Buckley N, Stanbrook M, Isbister G, Bennett M, McGuigan M. Hyperbaric oxygen for carbon monoxide poisoning. The Cochrane Database of Systematic Reviews 2005, Issue 1. [DOI: 10.1002/14651858.CD002041.pub2] - DOI - PubMed

MeSH terms